Interleukin‐18 and diabetic nephropathy: a review

H Yaribeygi, SL Atkin… - Journal of cellular …, 2019 - Wiley Online Library
The inflammatory response has an important role in the pathophysiology of diabetic
nephropathy that is contributed to by inflammatory mediators such as interleukin‐1 (IL‐1), IL …

Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications

T Fujita, N Ogihara, Y Kamura, A Satomura, Y Fuke… - Acta …, 2012 - Springer
Diabetic complication is comprised of a wide variety of pathophysiological factors involving
proinflammatory cytokines, adipokines, and oxidative stress, among others. Each of these …

Interleukin 17A promotes diabetic kidney injury

J Ma, YJ Li, X Chen, T Kwan, SJ Chadban, H Wu - Scientific reports, 2019 - nature.com
The role of the pro-inflammatory cytokine IL-17 in the pathogenesis of numerous
inflammatory disorders is well-documented, but conflicting results are reported for its role in …

Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-β1 enhanced IL-18 expression in human renal proximal tubular epithelial cells

K Miyauchi, Y Takiyama, J Honjyo, M Tateno… - Diabetes research and …, 2009 - Elsevier
AIM: In order to clarify the importance of Interleukin (IL)-18 in the development of diabetic
nephropathy (DN), we evaluated the expressions of IL-18 in diabetic kidney. METHODS: We …

Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation

S Wang, Y Li, J Fan, X Zhang, J Luan, Q Bian… - Cell death & …, 2017 - nature.com
Diabetic nephropathy (DN) is one of the most lethal complications of diabetes mellitus with
metabolic disorders and chronic inflammation. Although the cytokine IL-22 was initially …

The role of IL-18 in type 1 diabetic nephropathy: the problem and future treatment

NM Elsherbiny, MMH Al-Gayyar - Cytokine, 2016 - Elsevier
Diabetic vascular complication is a leading cause of diabetic nephropathy, a progressive
increase in urinary albumin excretion coupled with elevated blood pressure leading to …

IL-6 signaling in diabetic nephropathy: From pathophysiology to therapeutic perspectives

E Feigerlová, SF Battaglia-Hsu - Cytokine & growth factor reviews, 2017 - Elsevier
Diabetic nephropathy (DN) is a leading cause of chronic kidney disease (CKD). Interleukin-6
(IL-6) signaling participates in inflammation responses central to the progression of DN …

[HTML][HTML] Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy

C Lavoz, YS Matus, M Orejudo, JD Carpio, A Droguett… - Kidney International, 2019 - Elsevier
Diabetic nephropathy (DN) is one of the most common complications of diabetes, and
currently the first end-stage renal disease worldwide. New strategies to treat DN using …

Low-dose IL-17 therapy prevents and reverses diabetic nephropathy, metabolic syndrome, and associated organ fibrosis

R Mohamed, C Jayakumar, F Chen… - Journal of the …, 2016 - journals.lww.com
Diabetes is the leading cause of kidney failure, accounting for> 45% of new cases of
dialysis. Diabetic nephropathy is characterized by inflammation, fibrosis, and oxidant stress …

In situ hybridization of interleukin 6 in diabetic nephropathy

D Suzuki, M Miyazaki, R Naka, T Koji, M Yagame… - Diabetes, 1995 - Am Diabetes Assoc
Increased mesangial expansion is one of the most characteristic histological changes in
diabetic nephropathy (DN). Although the pathogenesis of DN remains unclear, recent …